ahlam1399
06-27-2016, 04:17 PM
Allergy Therapeutics says study fails to find hay fever therapy dose range
(Reuters) - Drug developer Allergy Therapeutics Plc said a study on suitable doses of its therapy to treat grass allergic rhinitis, or hay fever, did **t find a recommended dose for a late-stage trial.http://feeds.feedburner.com/~ff/reuters/healthNews?d=yIl2AUoC8zA (http://feeds.reuters.com/~ff/reuters/healthNews?a=wYlkzuTguBI:uwZWGp4Zo4U:yIl2AUoC8zA) http://feeds.feedburner.com/~ff/reuters/healthNews?i=wYlkzuTguBI:uwZWGp4Zo4U:F7zBnMyn0Lo (http://feeds.reuters.com/~ff/reuters/healthNews?a=wYlkzuTguBI:uwZWGp4Zo4U:F7zBnMyn0Lo) http://feeds.feedburner.com/~ff/reuters/healthNews?i=wYlkzuTguBI:uwZWGp4Zo4U:V_sGLiPBpWU (http://feeds.reuters.com/~ff/reuters/healthNews?a=wYlkzuTguBI:uwZWGp4Zo4U:V_sGLiPBpWU)
http://feeds.feedburner.com/~r/reuters/healthNews/~4/wYlkzuTguBI
(Reuters) - Drug developer Allergy Therapeutics Plc said a study on suitable doses of its therapy to treat grass allergic rhinitis, or hay fever, did **t find a recommended dose for a late-stage trial.http://feeds.feedburner.com/~ff/reuters/healthNews?d=yIl2AUoC8zA (http://feeds.reuters.com/~ff/reuters/healthNews?a=wYlkzuTguBI:uwZWGp4Zo4U:yIl2AUoC8zA) http://feeds.feedburner.com/~ff/reuters/healthNews?i=wYlkzuTguBI:uwZWGp4Zo4U:F7zBnMyn0Lo (http://feeds.reuters.com/~ff/reuters/healthNews?a=wYlkzuTguBI:uwZWGp4Zo4U:F7zBnMyn0Lo) http://feeds.feedburner.com/~ff/reuters/healthNews?i=wYlkzuTguBI:uwZWGp4Zo4U:V_sGLiPBpWU (http://feeds.reuters.com/~ff/reuters/healthNews?a=wYlkzuTguBI:uwZWGp4Zo4U:V_sGLiPBpWU)
http://feeds.feedburner.com/~r/reuters/healthNews/~4/wYlkzuTguBI